Sound Income Strategies’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-37
Closed -$737 1383
2024
Q1
$737 Hold
37
﹤0.01% 1198
2023
Q4
$830 Hold
37
﹤0.01% 1181
2023
Q3
$748 Hold
37
﹤0.01% 1030
2023
Q2
$946 Sell
37
-34
-48% -$895 ﹤0.01% 983
2023
Q1
$2.11K Hold
71
﹤0.01% 833
2022
Q4
$1.92K Hold
71
﹤0.01% 774
2022
Q3
$2K Hold
71
﹤0.01% 680
2022
Q2
$2K Buy
71
+9
+15% +$259 ﹤0.01% 692
2022
Q1
$2K Hold
62
﹤0.01% 709
2021
Q4
$2K Hold
62
﹤0.01% 698
2021
Q3
$2K Hold
62
﹤0.01% 674
2021
Q2
$2K Hold
62
﹤0.01% 710
2021
Q1
$2.71K Hold
62
﹤0.01% 717
2020
Q4
$3K Hold
62
﹤0.01% 651
2020
Q3
$2K Hold
62
﹤0.01% 648
2020
Q2
$2K Hold
62
﹤0.01% 621
2020
Q1
$2K Buy
62
+25
+68% +$747 ﹤0.01% 569
2019
Q4
$1K Hold
37
﹤0.01% 607
2019
Q3
$1K Hold
37
﹤0.01% 576
2019
Q2
$2K Buy
+37
New +$1.58K ﹤0.01% 540

Other funds holding AVNS

Sound Income Strategies's AVNS Position: Q2 2024 in Review

Sound Income Strategies sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 37 shares — an estimated $737 sold.

Sound Income Strategies first reported a position in AVNS in Q2 2019 and held it in 20 quarters. The position peaked at $3K in Q4 2020. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • Sound Income Strategies reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • Sound Income Strategies sold 37 Avanos Medical shares in Q2 2024, an estimated $737.
  • Sound Income Strategies first reported a position in Avanos Medical in Q2 2019 and held it in 20 quarters.
  • Sound Income Strategies's Avanos Medical position peaked at $3K in Q4 2020.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Sound Income Strategies's 13F filing for Q2 2024, filed 12 Jul 2024.